<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
  <channel>
    <title><![CDATA[PeRSSonalized Leukemia Journals on Webicina.Com]]></title>
    <link>http://www.webicina.com/perssonalized/?cat=15</link>
    <description>Follow PeRSSonalized Leukemia Journals on Webicina.Com</description>
    
      <item>
        <title><![CDATA[A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm]]></title>
        <link>http://feeds.nature.com/~r/leu/rss/current/~3/CaLaHo_pKg4/leu.2012.286</link>
        <description><![CDATA[]]></description>
        <pubDate>Thu, 09 May 2013 01:45:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Exome sequencing in tracking clonal evolution in multiple myeloma following therapy]]></title>
        <link>http://feeds.nature.com/~r/leu/rss/current/~3/RTUNjtWbVio/leu.2012.287</link>
        <description><![CDATA[]]></description>
        <pubDate>Thu, 09 May 2013 01:45:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Matriptase is highly upregulated in chronic lymphocytic leukemia and promotes cancer cell invasion]]></title>
        <link>http://feeds.nature.com/~r/leu/rss/current/~3/4m0vz0FsMuc/leu.2012.289</link>
        <description><![CDATA[]]></description>
        <pubDate>Thu, 09 May 2013 01:45:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Evaluation of WT1 expression in bone marrow vs peripheral blood samples of children with acute myeloid leukemia—impact on minimal residual disease detection]]></title>
        <link>http://feeds.nature.com/~r/leu/rss/current/~3/8wnT7BxImpE/leu.2012.291</link>
        <description><![CDATA[]]></description>
        <pubDate>Thu, 09 May 2013 01:45:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study]]></title>
        <link>http://feeds.nature.com/~r/leu/rss/current/~3/MLPqQ5mx2SQ/leu.2012.292</link>
        <description><![CDATA[]]></description>
        <pubDate>Thu, 09 May 2013 01:45:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Proton pump inhibitors significantly increase the intracellular concentration of nilotinib, but not imatinib in target CML cells]]></title>
        <link>http://feeds.nature.com/~r/leu/rss/current/~3/uv6_XlwJ_Oo/leu.2012.295</link>
        <description><![CDATA[]]></description>
        <pubDate>Thu, 09 May 2013 01:45:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia]]></title>
        <link>http://feeds.nature.com/~r/leu/rss/current/~3/GGvKNcnDvM0/leu.2012.306</link>
        <description><![CDATA[]]></description>
        <pubDate>Thu, 09 May 2013 01:45:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Eltrombopag inhibition of acute myeloid leukemia cell survival does not depend on c-Mpl expression]]></title>
        <link>http://feeds.nature.com/~r/leu/rss/current/~3/kbfGpvrYkx8/leu.2012.310</link>
        <description><![CDATA[]]></description>
        <pubDate>Thu, 09 May 2013 01:45:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Differential roles of Kras and Pten in murine leukemogenesis]]></title>
        <link>http://feeds.nature.com/~r/leu/rss/current/~3/LouSA4UqaYU/leu.2012.316</link>
        <description><![CDATA[]]></description>
        <pubDate>Thu, 09 May 2013 01:45:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia]]></title>
        <link>http://feeds.nature.com/~r/leu/rss/current/~3/3Pqgbs05lm8/leu.2013.22</link>
        <description><![CDATA[]]></description>
        <pubDate>Thu, 09 May 2013 01:45:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Call for case histories of BMT in patients with coincident schizophrenia]]></title>
        <link>http://feeds.nature.com/~r/leu/rss/current/~3/YPxnMa3kmCc/leu.2013.32</link>
        <description><![CDATA[]]></description>
        <pubDate>Thu, 09 May 2013 01:45:08 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[MicroRNA profiling reveals aberrant microRNA expression in adult ETP-ALL and functional studies implicate a role for miR-222 in acute leukemia]]></title>
        <link>http://www.lrjournal.com/article/PIIS0145212613000738/abstract?rss=yes</link>
        <description><![CDATA[Abstract: Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) has been identified as high-risk subgroup in acute T-cell lymphoblastic leukemia (T-ALL). To investigate the immature and myeloid nature of ETP-ALL we examined global microRNA (m]]></description>
        <pubDate>Fri, 03 May 2013 00:54:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: A multicenter, randomized control trial in southwest China]]></title>
        <link>http://www.lrjournal.com/article/PIIS0145212613000805/abstract?rss=yes</link>
        <description><![CDATA[Abstract: In a well-controlled multi-center randomized trial in southwestern China, 228 patients with refractory or relapsed AML were received a low-dose CAG regimen either with etoposide (E-CAG) or without etoposide (CAG). The complete remission (CR]]></description>
        <pubDate>Fri, 03 May 2013 00:54:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[TCTP/HRF pathway and angiogenesis: A feasible intercourse in chronic lymphocytic leukemia]]></title>
        <link>http://www.lrjournal.com/article/PIIS0145212613000192/abstract?rss=yes</link>
        <description><![CDATA[Abstract: This prospective study was planned to determine the intercourse between translationally controlled tumor protein (TCTP)/histamine releasing factor (HRF)/histamine pathway and angiogenesis in chronic lymphocytic leukemia (CLL). A total of 15]]></description>
        <pubDate>Fri, 03 May 2013 00:54:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Absolute lymphocyte count is associated with minimal residual disease level in childhood B-cell precursor acute lymphoblastic leukemia]]></title>
        <link>http://www.lrjournal.com/article/PIIS0145212613000404/abstract?rss=yes</link>
        <description><![CDATA[Abstract: The prognostic value of absolute lymphocyte count (ALC) has been a recent matter of debate in childhood acute lymphoblastic leukemia (ALL). In the current study, ALCs at the time of diagnosis (ALC-0), after 7 days of initial therapy (ALC-8)]]></description>
        <pubDate>Fri, 03 May 2013 00:54:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines]]></title>
        <link>http://www.lrjournal.com/article/PIIS0145212613000763/abstract?rss=yes</link>
        <description><![CDATA[Abstract: Erythropoiesis-stimulating agents (ESA) are used commonly to reduce symptomatic anemia in patients with myelodysplastic syndromes (MDS). We assessed population-based patterns of ESA use relative to treatment guidelines using data from the S]]></description>
        <pubDate>Fri, 03 May 2013 00:54:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Extended lifespan of normal human B lymphocytes experimentally infected by SV40 or transfected by SV40 large T antigen expression vector]]></title>
        <link>http://www.lrjournal.com/article/PIIS0145212613000416/abstract?rss=yes</link>
        <description><![CDATA[Abstract: SV40 footprints were detected in different lymphoproliferative disorders and in blood specimens of healthy donors. However, little is known on the ability of SV40 to infect/transform normal human B-lymphocytes. In this in vitro study, exper]]></description>
        <pubDate>Fri, 03 May 2013 00:54:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[A novel bioluminescent bacterial biosensor for measurement of Ara-CTP and cytarabine potentiation by fludarabine in seven leukaemic cell lines]]></title>
        <link>http://www.lrjournal.com/article/PIIS0145212613000507/abstract?rss=yes</link>
        <description><![CDATA[Abstract: This study evaluates an in vitro biosensor assay capable of detecting the intracellular levels of the tri-phosphorylated form of cytarabine (Ara-CTP) within one working day. The biosensor predicted the response of seven leukaemic cell lines]]></description>
        <pubDate>Fri, 03 May 2013 00:54:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Combined inhibition of the phosphoinosityl-3-kinase (PI3Kinase) P110δ subunit and mitogen-extracellular activated protein kinase (MEKinase) shows synergistic cytotoxicity against human acute myeloid leukemia progenitors]]></title>
        <link>http://www.lrjournal.com/article/PIIS0145212613000787/abstract?rss=yes</link>
        <description><![CDATA[Abstract: Treatment of 32 acute myeloid leukemia (AML) blast samples showing activation of the PI3K and RAS/RAF/MEK/ERK pathways with the PI3K p110δ isoform and MEKinase selective inhibitors, PCN5603 and U0126 produced dose dependent progenitor kill]]></description>
        <pubDate>Fri, 03 May 2013 00:54:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Bone morphogenetic proteins regulate differentiation of human promyelocytic leukemia cells]]></title>
        <link>http://www.lrjournal.com/article/PIIS0145212613000775/abstract?rss=yes</link>
        <description><![CDATA[Abstract: We investigated the role of bone morphogenetic proteins (BMPs) in suppression of all-trans retinoic acid (ATRA)-mediated differentiation of leukemic promyelocytes. In NB4 and HL60 cell lines, BMPs reduced the percentage of differentiated ce]]></description>
        <pubDate>Fri, 03 May 2013 00:54:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Occurrence and current management of side effects in chronic myeloid leukemia patients treated frontline with tyrosine kinase inhibitors]]></title>
        <link>http://www.lrjournal.com/article/PIIS0145212613000374/abstract?rss=yes</link>
        <description><![CDATA[Abstract: Tyrosine kinase inhibitors (TKIs) represent the gold standard therapy of chronic myeloid leukemia and, after being used in imatinib resistant patients, dasatinib and nilotinib are now also used in frontline. In this article, we review data ]]></description>
        <pubDate>Fri, 03 May 2013 00:54:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[No evidence for ITSN1 loss in a patient with mental retardation and complex chromosomal rearrangements of 21q21–21q22]]></title>
        <link>http://www.lrjournal.com/article/PIIS0145212613000672/abstract?rss=yes</link>
        <description><![CDATA[Intersectin 1 (ITSN1) was postulated as candidate gene for mental retardation in patients with deletions in 21q by two independent groups . We report here on a mentally retarded patient, who developed myelodysplastic syndrome (MDS) at age 43. Followi]]></description>
        <pubDate>Fri, 03 May 2013 00:54:04 +0200</pubDate>
      </item>
      
      <item>
        <title><![CDATA[pubmed: "leukemia : official...]]></title>
        <link>http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Leukemia%20%3A%20official%20journal%20of%20the%20Leukemia%20Society%20of%20America%2C%20Leukemia%20Research%20Fund%2C%20U.K%22%5BJournal%5D</link>
        <description><![CDATA[NCBI: db=pubmed; Term="Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K"[Journal]]]></description>
        <pubDate>Tue, 26 Mar 2013 12:36:09 +0100</pubDate>
      </item>
      
      <item>
        <title><![CDATA[pubmed: "leukemia : official...]]></title>
        <link>http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Leukemia%20%3A%20official%20journal%20of%20the%20Leukemia%20Society%20of%20America%2C%20Leukemia%20Research%20Fund%2C%20U.K%22%5BJournal%5D</link>
        <description><![CDATA[NCBI: db=pubmed; Term="Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K"[Journal]]]></description>
        <pubDate>Tue, 26 Mar 2013 12:36:09 +0100</pubDate>
      </item>
      
      <item>
        <title><![CDATA[pubmed: "leukemia : official...]]></title>
        <link>http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Leukemia%20%3A%20official%20journal%20of%20the%20Leukemia%20Society%20of%20America%2C%20Leukemia%20Research%20Fund%2C%20U.K%22%5BJournal%5D</link>
        <description><![CDATA[NCBI: db=pubmed; Term="Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K"[Journal]]]></description>
        <pubDate>Tue, 19 Feb 2013 09:07:09 +0100</pubDate>
      </item>
      
      <item>
        <title><![CDATA[pubmed: "leukemia : official...]]></title>
        <link>http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Leukemia%20%3A%20official%20journal%20of%20the%20Leukemia%20Society%20of%20America%2C%20Leukemia%20Research%20Fund%2C%20U.K%22%5BJournal%5D</link>
        <description><![CDATA[NCBI: db=pubmed; Term="Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K"[Journal]]]></description>
        <pubDate>Tue, 19 Feb 2013 09:07:09 +0100</pubDate>
      </item>
      
      <item>
        <title><![CDATA[pubmed: "leukemia : official...]]></title>
        <link>http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Leukemia%20%3A%20official%20journal%20of%20the%20Leukemia%20Society%20of%20America%2C%20Leukemia%20Research%20Fund%2C%20U.K%22%5BJournal%5D</link>
        <description><![CDATA[NCBI: db=pubmed; Term="Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K"[Journal]]]></description>
        <pubDate>Tue, 19 Feb 2013 09:07:08 +0100</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Low GFI1 expression in white blood cells of CP-CML patients at diagnosis is strongly associated with subsequent blastic transformation.]]></title>
        <link>http://www.ncbi.nlm.nih.gov/PubMed/23411466?dopt=Abstract</link>
        <description><![CDATA[
	
        Low GFI1 expression in white blood cells of CP-CML patients at diagnosis is strongly associated with subsequent blastic transformation.
        Leukemia. 2013 Feb 15;
        Authors:  Kok CH, Watkins DB, Leclercq T, D'Andrea RJ, [...]]]></description>
        <pubDate>Sat, 16 Feb 2013 17:25:09 +0100</pubDate>
      </item>
      
      <item>
        <title><![CDATA[A novel therapeutic molecule against HTLV-1 infection targeting provirus.]]></title>
        <link>http://www.ncbi.nlm.nih.gov/PubMed/23411465?dopt=Abstract</link>
        <description><![CDATA[
	
        A novel therapeutic molecule against HTLV-1 infection targeting provirus.
        Leukemia. 2013 Feb 15;
        Authors:  Tanaka A, Takeda S, Kariya R, Matsuda K, Urano E, Okada S, Komano J
        Abstract
        Human T cell  [...]]]></description>
        <pubDate>Sat, 16 Feb 2013 17:25:09 +0100</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Genome-wide Profiling Reveals Epigenetic Inactivation of the PU.1 Pathway by Histone H3 Lysine 27 Tri-methylation in Cytogenetically Normal Myelodysplastic Syndrome.]]></title>
        <link>http://www.ncbi.nlm.nih.gov/PubMed/23411464?dopt=Abstract</link>
        <description><![CDATA[
	
        Genome-wide Profiling Reveals Epigenetic Inactivation of the PU.1 Pathway by Histone H3 Lysine 27 Tri-methylation in Cytogenetically Normal Myelodysplastic Syndrome.
        Leukemia. 2013 Feb 15;
        Authors:  Cheng JX, Anas [...]]]></description>
        <pubDate>Sat, 16 Feb 2013 17:25:09 +0100</pubDate>
      </item>
      
      <item>
        <title><![CDATA[Stromal cell-induced miRNA alteration in chronic lymphocytic leukaemia: how a minute and unavoidable cell contamination impairs miRNA profiling.]]></title>
        <link>http://www.ncbi.nlm.nih.gov/PubMed/23407459?dopt=Abstract</link>
        <description><![CDATA[
	Related Articles
        Stromal cell-induced miRNA alteration in chronic lymphocytic leukaemia: how a minute and unavoidable cell contamination impairs miRNA profiling.
        Leukemia. 2013 Feb 14;
        Authors:  Paggetti J, Berchem [...]]]></description>
        <pubDate>Fri, 15 Feb 2013 19:49:05 +0100</pubDate>
      </item>
      
      <item>
        <title><![CDATA[High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.]]></title>
        <link>http://www.ncbi.nlm.nih.gov/PubMed/23407458?dopt=Abstract</link>
        <description><![CDATA[
	Related Articles
        High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
        Leukemia. 2013 Feb 14;
        Authors:  Marshall GM, Dalla Poz [...]]]></description>
        <pubDate>Fri, 15 Feb 2013 19:49:05 +0100</pubDate>
      </item>
      
      <item>
        <title><![CDATA[The AAA(+) ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis.]]></title>
        <link>http://www.ncbi.nlm.nih.gov/PubMed/23403462?dopt=Abstract</link>
        <description><![CDATA[
	Related Articles
        The AAA(+) ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis.
        Leukemia. 2013 Feb 13;
        Authors:  Osaki H, Walf-Vorderwülbecke V, Mangolini M, Zhao L, Horton SJ, Morrone G, Schuringa JJ, De  [...]]]></description>
        <pubDate>Thu, 14 Feb 2013 21:19:07 +0100</pubDate>
      </item>
  
  </channel>
</rss>
